Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
6.28
+0.42 (7.17%)
Dec 20, 2024, 4:00 PM EST - Market closed
Enanta Pharmaceuticals Employees
Enanta Pharmaceuticals had 145 employees as of September 30, 2023. The number of employees decreased by 15 or -9.38% compared to the previous year.
Employees
145
Change (1Y)
-15
Growth (1Y)
-9.38%
Revenue / Employee
$466,448
Profits / Employee
-$800,310
Market Cap
133.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
American Well | 1,104 |
Akoya Biosciences | 330 |
Protalix BioTherapeutics | 208 |
InflaRx | 62 |
Black Diamond Therapeutics | 54 |
Elutia | 54 |
Galectin Therapeutics | 14 |
Atossa Therapeutics | 12 |
ENTA News
- 12 days ago - Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV) - Business Wire
- 15 days ago - Enanta Pharmaceuticals to Present Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for Respiratory Syncytial Virus (RSV) - Business Wire
- 26 days ago - Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024 - Business Wire
- 3 months ago - Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV) - Business Wire
- 3 months ago - Enanta Pharmaceuticals to Participate in Investor Conferences in September - Business Wire
- 4 months ago - Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter - Business Wire
- 7 months ago - Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference - Business Wire
- 8 months ago - Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference - Business Wire